Back to top
more

Cardinal Health (CAH)

(Delayed Data from NYSE)

$111.93 USD

111.93
1,359,353

-0.62 (-0.55%)

Updated Oct 17, 2024 04:00 PM ET

After-Market: $111.94 +0.01 (0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 36% (161 out of 250)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Is Cardinal Health (CAH) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Derek Lewis headshot

3 Top S&P 500 Performers of 2022

by Derek Lewis

Investors are more than aware of how harsh the market has been in 2022, with many stocks residing in the red year-to-date. Still, these three stocks have snapped the bearish trend, delivering substantial gains to shareholders.

3 Reasons Why Cardinal (CAH) Is a Great Growth Stock

by Zacks Equity Research

Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.

Indrajit Bandyopadhyay headshot

3 Medical Stocks Creating Wealth Despite Macro Challenges

by Indrajit Bandyopadhyay

Here we discuss three stocks - CAH, LNTH and TMDX - that have been creating wealth for their investors in 2022 as several competitors faltered amid macro challenges. Will the trend continue?

Should SPDR Portfolio S&P 500 High Dividend ETF (SPYD) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for SPYD

The Zacks Analyst Blog Highlights Enphase Energy, Halliburton, Cardinal Health and W.R. Berkley

by Zacks Equity Research

Enphase Energy, Halliburton, Cardinal Health and W.R. Berkley are included in this Analyst Blog.

Why Is Dentsply (XRAY) Up 1% Since Last Earnings Report?

by Zacks Equity Research

Dentsply (XRAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Madhurima Das headshot

4 S&P 500 Stocks Up More Than 30% YTD With More Room to Run

by Madhurima Das

Despite the S&P 500 incurring a 15.7% YTD loss owing to inflation and high interest rates, stocks like ENPH, HAL, CAH and WRB have soared. They are poised to maintain the momentum in 2023.

Is Acer Therapeutics (ACER) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how Acer Therapeutics Inc. (ACER) and Cardinal Health (CAH) have performed compared to their sector so far this year.

Is SPDR Portfolio S&P 500 High Dividend ETF (SPYD) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for SPYD

Zacks Investment Ideas feature highlights: McKesson, Cardinal Health and Super Micro Computer

by Zacks Equity Research

McKesson, Cardinal Health and Super Micro Computer are part of the Zacks Investment Ideas article.

Derek Lewis headshot

3 Stocks Silently Outperforming Energy in 2022

by Derek Lewis

Outperforming the Zacks Oils and Energy sector in 2022 is no easy task. However, bulls have silently roamed in all three of these stocks, breaking the overall bearish trend we've become accustomed to.

Is WisdomTree U.S. MidCap Dividend ETF (DON) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for DON

Here's Why You Should Retain Cardinal Health (CAH) Stock Now

by Zacks Equity Research

Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and a diversified product portfolio. However, the cost of products continues to rise.

Cardinal Health's (CAH) Velocare to Enhance at-Home Care

by Zacks Equity Research

Cardinal Health's (CAH) latest launch is expected to significantly expand its at-Home Solutions supply chain and logistics services, thereby improving patient care.

Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RYH)?

by Zacks Equity Research

Sector ETF report for RYH

Is Invesco S&P 500 Equal Weight Health Care ETF (RYH) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for RYH

Company News for Nov 7, 2022

by Zacks Equity Research

Companies In The News Are: ENB, CAH, WPC, EVRG.

Should WisdomTree U.S. MidCap Dividend ETF (DON) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for DON

Cardinal Health (CAH) Q1 Earnings and Revenues Top Estimates

by Zacks Equity Research

Cardinal Health's (CAH) fiscal first-quarter results benefit from the solid performance of the Pharmaceutical segment.

    Cardinal Health (CAH) Q1 Earnings and Revenues Surpass Estimates

    by Zacks Equity Research

    Cardinal (CAH) delivered earnings and revenue surprises of 25% and 5.81%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

    Staar Surgical (STAA) Q3 Earnings and Revenues Beat Estimates

    by Zacks Equity Research

    Staar Surgical (STAA) delivered earnings and revenue surprises of 76.19% and 1.97%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

    Is Invesco Defensive Equity ETF (DEF) a Strong ETF Right Now?

    by Zacks Equity Research

    Smart Beta ETF report for DEF

    Cardinal Health (CAH) Dips More Than Broader Markets: What You Should Know

    by Zacks Equity Research

    In the latest trading session, Cardinal Health (CAH) closed at $75.90, marking a -1.61% move from the previous day.

    Cardinal Health (CAH) to Post Q1 Earnings: What's in Store?

    by Zacks Equity Research

    Cardinal Health's (CAH) first-quarter fiscal 2023 results are likely to reflect solid performance in the Pharmaceutical segment. However, inflation and supply chain constraints are likely to have continued.